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Two cases presenting as an acute exacerbation of idiopathic pulmonary fibrosis (IPF) are
presented. Both patients had good response to corticosteroids and exhibited the
underlying pathology of organizing pneumonia superimposed on usual interstitial
pneumonia. The challenges with diagnosing an IPF exacerbation in patients with previously
unknown IPF are discussed. The impact of underlying histopathology during an
exacerbation on patient outcomes is also discussed.
& 2007 Elsevier Ltd. All rights reserved.Rapid clinical deterioration in patients with idiopathic
pulmonary fibrosis (IPF) has been increasingly recognized
over the past decade.1–4 This ‘‘acute exacerbation’’ of IPF is
characterized by accelerated deterioration in lung function
and is fatal in a significant proportion of affected
patients.1,2,4 Most reports to date have emphasized the
occurrence of acute exacerbations in patients with known
IPF.4 This report highlights the initial presentation of IPF as
an acute exacerbation discussing the diagnostic challenges
encountered in this setting. It also discusses the impact of
lung histopathology on patient outcomes from an acute IPF
exacerbation.Elsevier Ltd. All rights reserved.
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A 69-year old male was admitted with worsening shortness
of breath and a dry nonproductive cough occurring over a
3-week period. He had complaints of mild exertional
dyspnea for 2 years prior to this. The patient was a non-
smoker but gave a history of diesel, asbestos and fiberglass
exposure. His examination was remarkable for severe
hypoxemia, tachypnea and bibasilar inspiratory crackles on
chest auscultation. Laboratory studies revealed leucocytosis
with normal hemoglobin and albumin levels. Antinuclear
antigen (ANA), antineutrophilic cytoplasmic antibody
(ANCA), Jo-1 antibody, Scl-70, anti-citrullinated antibody
and mycoplasma titers were negative. Rheumatoid factor
(RF) and C-reactive protein (CRP) levels were markedly
elevated. Computed tomography (CT) of the chest showed
bilateral ground-glass opacities with ill-defined reticular
changes (Figure 1A). The patient declined to undergo a
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Figure 1 Serial chest HRCT scans in Case 1. (A) During first
acute IPF exacerbation. (B) Following resolution of first IPF
exacerbation showing peripheral reticular opacities suggestive
of UIP pattern. (C) During second IPF exacerbation showing new
ground-glass opacities.
K.M. Sundar, D.L. Harris44surgical or bronchoscopic biopsy and was empirically started
on high-dose corticosteroids (methylprednisolone 240mg/day)
and antibiotics for community-acquired pneumonia. His con-
dition improved, and he was discharged on a tapering dose of
prednisone over the next 8 weeks. CRP levels normalized and
his RF titers fell from 27 to 17U (normal 0–14 IU/mL).
During follow-up, his respiratory status improved
(Graph 1), and chest CT scans showed resolution of
ground-glass opacities but peripheral reticular changes
suggestive of an underlying usual interstitial pneumonia
(UIP) were noted (Figure 1B). Nine months later, he
presented with a weeklong history of exertional dyspnea
and nonproductive cough. Chest CT scans showed super-
imposition of ground-glass opacities with peripheral honey-
combing (Figure 1C). Laboratory studies showed elevation of
CRP values and leucocytosis with a left shift. RF titers were
increased to 45 IU/mL and Chlamydia pneumoniae IgG titers
were at 1:256. Bronchoalveolar lavage (BAL) revealed 48%
lymphocytes, 35% macrophages and 10% neutrophils without
any growth of a specific pathogen. He was treated with high-
dose corticosteroids and intravenous azithromycin with an
excellent response. On follow-up, he had an improvement in
his pulmonary function tests (Graph 1). A video-assisted
thoracoscopic surgical (VATS) biopsy done 3 months later
showed changes of UIP with numerous fibroblastic foci and
patchy organizing pneumonia (Figure 2A and B).
Case 2
A 71-year old white female presented with increasing
dyspnea and a nonproductive cough for a 3-week period.
She was admitted with resting room air hypoxemia, and
bilateral diffuse ground-glass opacities on chest radio-
graphs. She denied any prior history of smoking or inhala-
tional exposures. Laboratory studies revealed normal CBC,
ESR of 46mm/h and a negative serological workup for
connective tissue diseases and atypical pneumonia. CT scans
of the chest showed interlobular septal thickening in lower
lobes with diffuse patchy areas of ground-glass opacities
(Figure 3). BAL from multiple lung lobes revealed 50–60%
macrophages, 30–45% lymphocytes and 10% neutrophils.
Pulmonary function tests revealed FVC of 1.67 L (52% predic-
ted), FEV1/FVC ratio of 87%, DLCO of 4.5mL/mmHg/min
(18% predicted). A VATS biopsy revealed features of
organizing pneumonia superimposed on a background of
UIP (Figure 4A and B). Patient was placed on high-dose
steroids with good clinical response, and follow-up pulmon-
ary function tests a month later showed improvement in FVC
to 1.96 L and DLCO to 10.5mL/mmHg/min.
Discussion
Acute exacerbations of IPF are characterized by the
occurrence of acute lung injury superimposed on preexisting
UIP.3 The exact nature of the acute injury appears to be
variable, ranging from diffuse alveolar damage (DAD) to
organizing pneumonia.5 Acute exacerbations impact the
natural history of IPF significantly, and this has been better
appreciated in the last decade. Based on historical data,
patients with IPF live less than 2 years following their
diagnosis, although considerable variation occurs in the
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Graph 1 Pulmonary function tests (PFTs) showing improve-
ment to baseline following resolution of first acute exacerbation
and worsening during second IPF exacerbation. Arrows point to
timing of the exacerbations.
Figure 2 Surgical biopsy from Case 1. Panel (A): At scanning
magnification the characteristic temporal heterogeneity of UIP
is evident, with fibrosis encircling lobules and normal lung
present at lobule centers (nl). Fibroblast foci are present and
there are areas with metaplastic bone (b), the latter a
manifestation of chronicity. Panel (B): Scattered throughout
the biopsy were areas of organizing pneumonia pattern (o)
subacute lung injury, occupying lobules to variable degree and
accompanied by squamous metaplasia of the terminal airways
(m). Microscopic honeycombing is present (mhc). Hematoxylin
and eosin stain. Panel (A): 12.5 original magnification; Panel
(B): 40 original magnification.
Initial presentation of idiopathic pulmonary fibrosis 45disease course for individual patients.6 Progression of
disease with development of honeycombed end-stage lung
was traditionally believed to be the main reason for
respiratory failure in a study that summarized the causes
of death in 326 IPF patients from six studies.7 A recent study,
however, showed that 47% of deaths in patients with early
lung impairment (FVC450%) occurred due to acute respira-
tory deteriorations.8 Because the concept of acute exacer-
bation of IPF has evolved relatively recently, it is difficult to
say how many IPF deaths in previous analyses were due to
acute exacerbations.7 Moreover, consensus-derived patho-
logic definitions of the idiopathic interstitial lung diseases
have been agreed upon only in the last decade, making it
difficult to adequately separate true IPF patients from other
interstitial diseases in prior series.9 There is also no
agreement on the clinical or pathologic definition of an
acute IPF exacerbation. Currently used criteria include:
(1) development of clinical deterioration over 1 month,
(2) occurrence of new radiographic opacities and (3) exclusion
of other possible etiologies such as infection, medication
toxicity, thromboembolic disease and heart failure.1–4
We describe two patients with previously undiagnosed IPF
who presented with acute exacerbations. Both of these
patients were diagnosed with underlying IPF only after
adequate histopathological specimens were obtained after
extensive workups for infectious and non-infectious causes
had been performed. Although a prior history of chronic
cough and dyspnea were elicited, no other clinical finding
was found to suggest the possibility of preexisting IPF in
either patient. Even though CT scans were suggestive of ill-
defined reticular abnormalities, none of these patients had
peripheral honeycombing or traction bronchiectasis.
In patients with IPF exacerbations, infectious pneumonia
remains a particular concern. In the study by Panos et al. of
543 patients, only 2–4% of patients had documented
respiratory infections.7 In other studies looking at the
incidence of infection in IPF patients with acute respiratory
failure, rates of infectious pneumonia have varied and it is
unclear how many of these documented infections occurred
nosocomially.10,11 BAL is commonly performed to excludeinfection in patients in those who can tolerate this
procedure. Although one report has emphasized the
predominance of neutrophils in the BAL of patients with
acute IPF exacerbations,4 this was not present in either of
our patients.
The pathology in both our cases was that of organizing
pneumonia superimposed on underlying IPF. DAD has been
the predominant superimposed abnormality in other pub-
lished studies on patients with IPF exacerbations,3 although
a recent study by Churg et al. has shown the occurrence of
significant proportion of superimposed organizing pneumo-
nia in patients with UIP.5 Although previous studies on IPF
exacerbations showed a high mortality rate,2–4 this has not
been borne out in reports on IPF exacerbations with the
underlying pathology of superimposed organizing pneumonia
on UIP.5,12 Both our patients exhibited the pathology of UIP
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Figure 4 Surgical biopsy from Case 2. Panel (A): At scanning
magnification the UIP pattern is evident with microscopic
honeycomb remodeling (mhc) alternating with areas of unin-
volved lung (nl). Patchy areas of organizing pneumonia pattern
are present within lobules (o), accompanied by mild chronic
inflammation. Panel (B): At higher magnification organizing
pneumonia pattern is seen (o) with associated mild chronic
inflammation (i) extending into adjacent alveolar walls.
Hematoxylin and eosin stain. Panel (A): 12.5 original
magnification; Panel (B): 100 original magnification.
Figure 3 Chest CT scan of Case 2 showing interlobular septal
thickening with patchy areas of ground-glass opacities.
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clinical response to corticosteroids. It can be argued that
Case 1 could have started out with the pathology of
superimposed DAD as the VATS lung biopsy was done quite
late in the course of his exacerbation. However, his dramatic
response to steroids, and the lack of corroborating features
to suggest a fibroproliferative DAD, makes superimposed
organizing pneumonia the likelier pathologic process under-
lying the exacerbation. Whether underlying histopathologic
patterns during an acute exacerbation reflect different
triggers and therefore different pathobiological bases
remain unknown. A study looking at the finding of organizing
pneumonia in transbronchial biopsies from patients with IPF
found that patients exhibiting such change had a subacute
disease onset, and a good response to steroids.13 Unfortu-
nately, the lack of adequate surgical biopsy specimens and
inadequate radiological information on these patients make
interpretation of this study results difficult.13 Acute inter-
stitial pneumonia (AIP) was an important diagnostic con-
sideration in both of our patients. Unlike IPF exacerbations,
patients with AIP tend to be younger and have a subacute
course with a shorter duration of respiratory symptoms.14
Laboratory and radiological abnormalities are very similar in
patients with AIP and IPF exacerbations, making their
differentiation difficult, especially in patients without
previously documented IPF.14 The finding of honeycombing
has been reported in fibrotic late stages of AIP,15 and it may
be difficult to distinguish AIP from acute IPF exacerbations
unless extensive honeycombing is noted on CTscans at initial
presentation that indicates underlying UIP.
Acute IPF exacerbations remain unpredictable occur-
rences in patients with IPF that cause significant morbidity
and mortality. Unlike COPD exacerbations that are easily
recognized even in patients without previously diagnosed
COPD, exacerbations of interstitial disease remain difficult
diagnostic and management problems. A high index of
suspicion is necessary to make a diagnosis in elderly patientswithout known IPF who present with diffuse air-space
disease that does not improve with therapies directed at
infectious pneumonia or other specific etiologies.Conflicts of interest
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